Page last updated: 2024-11-02

pioglitazone and Carcinoma 256, Walker

pioglitazone has been researched along with Carcinoma 256, Walker in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Carcinoma 256, Walker: A transplantable carcinoma of the rat that originally appeared spontaneously in the mammary gland of a pregnant albino rat, and which now resembles a carcinoma in young transplants and a sarcoma in older transplants. (Stedman, 25th ed)

Research Excerpts

ExcerptRelevanceReference
"Cachexia is a multifactorial syndrome characterized by profound involuntary weight loss, fat depletion, skeletal muscle wasting, and asthenia; all symptoms are not entirely attributable to inadequate nutritional intake."5.42Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect. ( Andreotti, S; Batista, ML; Beluzi, M; Farmer, SR; Franco, FO; Henriques, FS; Knobl, P; Lima, FB; Neves, RX; Peres, SB; Santos, KB; Seelaender, M; Sertié, RA; Shida, CS, 2015)
"Cachexia is a multifactorial syndrome characterized by profound involuntary weight loss, fat depletion, skeletal muscle wasting, and asthenia; all symptoms are not entirely attributable to inadequate nutritional intake."1.42Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect. ( Andreotti, S; Batista, ML; Beluzi, M; Farmer, SR; Franco, FO; Henriques, FS; Knobl, P; Lima, FB; Neves, RX; Peres, SB; Santos, KB; Seelaender, M; Sertié, RA; Shida, CS, 2015)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beluzi, M1
Peres, SB1
Henriques, FS1
Sertié, RA1
Franco, FO1
Santos, KB1
Knobl, P1
Andreotti, S1
Shida, CS1
Neves, RX1
Farmer, SR1
Seelaender, M1
Lima, FB1
Batista, ML1

Other Studies

1 other study available for pioglitazone and Carcinoma 256, Walker

ArticleYear
Pioglitazone treatment increases survival and prevents body weight loss in tumor-bearing animals: possible anti-cachectic effect.
    PloS one, 2015, Volume: 10, Issue:3

    Topics: Adiponectin; Adipose Tissue; Animals; Body Weight; Cachexia; Carcinoma 256, Walker; CCAAT-Enhancer-B

2015